Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Caribou Biosciences Stock

Q: Can you buy Caribou Biosciences stock?

You can no longer buy Caribou Biosciencesstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

cariboubio.comHealthcare / BioTech & PharmaFounded: 2011Funding to Date: $41.55MM

Caribou Biosciences is a leading clinical-stage CRISPR genome editing biotechnology company developing an internal pipeline of off-the-shelf, genome-edited CAR-T and natural killer (NK) cell therapies.

Learn more about Caribou Biosciences IPO

Enterprise Value

Access valuation and stock price for companies like Caribou Biosciences before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Caribou Biosciences stock FAQs

Can you buy Caribou Biosciences stock?

You can no longer buy Caribou Biosciences stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Caribou Biosciences stock?

To invest in a private company like Caribou Biosciences through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Caribou Biosciences stock?

You can no longer sell stock of Caribou Biosciences on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Caribou Biosciences stock?

If you hold private company shares of Caribou Biosciences - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Caribou Biosciences stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Caribou Biosciences a public company?

No, Caribou Biosciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Caribou Biosciences’ stock price?

The stock price of Caribou Biosciences is $5.38 as of 1/18/24.

What is Caribou Biosciences’ stock ticker symbol?

The ticker symbol of Caribou Biosciences is CRBU.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Barbara McClung

Chief Legal Officer and Corporate Secretary

Timothy Herpin Ph.D

Chief Business Officer

Chris Fuller

Vice President, Informatics

Jennifer Doudna Ph.D

Co-Founder & Scientific Advisor

Steven Kanner Ph.D

Chief Scientific Officer

Edny Inui

Director, Business Development

James Berger

Co-Founder

Rachel Haurwitz Ph.D

Co-Founder, Board Member, President and Chief Executive Officer

Martin Jinek Ph.D

Co-Founder & Scientific Advisor

Scott Gradia Ph.D

Vice President of Platform Research

Board Members

Philip Austin

Anterra Capital

Robert Weisskoff Ph.D

Natalie Sacks MD

Rachel Haurwitz Ph.D

Business Wire 11/18/2019

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering wi

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.